Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing covers the month of August 2025, specifically detailing share repurchases executed on August 18, 2025. The company is a Foreign Private Issuer filing under Rule 13a-16 of the Securities Exchange Act of 1934.
Key Financial Metrics and Transaction Details
The filing details a specific block of share repurchases conducted as part of an existing buyback program. No revenue, profit, or cash flow data is provided in this specific document.
- Date of Purchase: August 18, 2025
- Shares Purchased (Daily): 221,293 ordinary shares
- Price Range (GBp): 1,433.00p (Low) to 1,443.00p (High)
- Volume-Weighted Average Price (GBp): 1,437.72p
- Trading Venue: London Stock Exchange (XLON)
- Broker: Merrill Lynch International
- Program Status: Non-discretionary agreement entered into on June 4, 2025.
- Cumulative Purchases (Since June 4, 2025): 24,364,286 ordinary shares
- Treasury Shares Held: 242,498,669 ordinary shares
- Shares in Issue (Excluding Treasury): 4,072,893,065 ordinary shares
- Treasury Voting Rights Percentage: 5.95%
Material Changes
The filing reports a reduction in the number of shares in issue and an increase in treasury shares held by the company. The total number of voting rights remains 4,072,893,065. The percentage of voting rights attributable to treasury shares is confirmed at 5.95% following this transaction. There are no other material changes to the company's financial position or operations disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains a standard cautionary statement regarding forward-looking statements. GSK notes that any projections are subject to risks and uncertainties that may cause actual results to differ materially. Specific risk factors are referenced in the company's Annual Report on Form 20-F for 2024 and its Q2 Results for 2025. No new guidance or specific management commentary regarding future financial performance is included in this transaction report.
Investor Verification Checklist
- Verify the total cumulative buyback volume since the June 4, 2025 agreement (24,364,286 shares).
- Confirm the current percentage of voting rights held in treasury (5.95%) against regulatory thresholds.
- Review the detailed schedule of individual trades to ensure compliance with market rules and the non-discretionary agreement terms.
- Check the updated share count in issue (4,072,893,065) for EPS calculations.
- Refer to the referenced Form 20-F (2024) and Q2 2025 results for broader risk factors and financial context not present in this filing.